What is the 13F Pro Quality Score for ADUS?

13F Pro ranks Addus HomeCare Corp (ADUS) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View ADUS's current score at https://13fpro.ai/company/ADUS (free sign-up required for the full ranking).

Where does 13F Pro source ADUS data?

All Addus HomeCare Corp fundamentals and ownership data come directly from SEC EDGAR. Addus HomeCare Corp files with the SEC under CIK 1468328. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is ADUS in?

Addus HomeCare Corp (ADUS) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives ADUS's revenue?

Per Addus HomeCare Corp's latest 10-Q filed with the SEC on 2026-08-04, the biggest revenue drivers are: Personal Care ($296.0M, +10.0% YoY); Hospice ($64.2M, +3.3% YoY); Home Health ($17.2M, -4.8% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/company/ADUS.

What are ADUS's largest expenses?

Addus HomeCare Corp's latest 10-Q reports these as the largest expense items: Cost of service revenues ($255.9M, +8.6% YoY); General and administrative expenses ($78.5M, +1.8% YoY); Depreciation and amortization ($4.1M, +5.4% YoY). Sourced directly from SEC EDGAR filing text for Q2 FY2026 (quarter ended June 30, 2026).

How often is ADUS research updated on 13F Pro?

ADUS's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

Addus HomeCare Corp(ADUS)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqmid

Institutional-grade research for retail investors

SEC EDGAR: CIK 1468328 ADUS stock profile & AI dashboard →

13F Pro Quality Score

64.2/100

Rank #568 of 2,961 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

73.6/100

Profitability

57.1/100

Balance Sheet

78.6/100

Earnings Quality

75.4/100

Free Cash Flow

56.8/100

Institutional Flow

36.2/100

Revenue Scale

57.7/100

Dilution Risk

53.0/100

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why ADUS Scores 64/100

exact factor attribution · 2026-09-11

ADUS's composite is driven by revenue growth and capital efficiency. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Revenue growth

+4.7 pts

74th pct

Capital efficiency

+2.9 pts

79th pct

Earnings quality

+2.5 pts

75th pct

Earnings growth

+1.4 pts

78th pct

Scale

+1.2 pts

58th pct

Profitability

+1.1 pts

57th pct

Free cash flow

+1.0 pts

57th pct

Shareholder dilution

+0.1 pts

53th pct

Institutional flow

-0.7 pts

36th pct

Latest change (2026-08-04): 67 → 64 · ↓ Revenue growth 75→59; ↓ Earnings growth 72→60

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

ADUS Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Addus HomeCare Corp (ADUS), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ADUS at 64.2/100 on a 32-signal composite quality model, placing it at rank #568 of 2,961 stocks — the top 25% of the AI-ranked universe. ADUS scores in the top quartile across balance sheet strength (78.6), earnings quality (75.4). Areas of concern include institutional flow (36.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Addus HomeCare Corp reports quarterly revenue of $377.4M, net income of $27.6M, an operating margin of 10.3%. Top institutional holders of ADUS by reported 13-F value include BlackRock, Capital Research Global Investors, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. ADUS trades on the Nasdaq exchange and files with the SEC under CIK 1468328. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ADUS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Addus HomeCare Corp directly from SEC EDGAR. Addus HomeCare Corp's 13F Pro composite quality score has ranged between 47 and 66 since 2021, currently 64.2 — an improving long-term trajectory across 68 quarterly and live scoring snapshots.

✦

Fun facts about Addus HomeCare Corp

Quirks, history, and lore behind ADUS — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare services company · small-cap · listed on Nasdaq · headquartered in Texas.
2
The Numbers
Generates roughly $1 billion in annual revenue and operates across multiple states, serving tens of thousands of patients every day.
3
The History
Founded in the 1970s in Illinois, it spent decades building a network before going public and eventually relocating its headquarters to the Lone Star State.
4
The Secret
Its core business isn't hospitals or clinics — it sends caregivers directly into patients' homes, keeping elderly and disabled individuals out of costlier institutional settings.
5
The Lore
It sits at the sweet spot of two unstoppable trends: an aging Baby Boomer population and a healthcare system desperate to cut costs by shifting care out of facilities and into homes.
6
The Giveaway
Its very name tells you what it does — "Addus" sounds like "add us" to your home, and HomeCare is right there in the company name. The ticker even rhymes with "radius."

▶ Think you know your stocks? Play the Daily Ticker

What's Driving ADUS's Business? Latest 10-Q Breakdown

✓ 29/29 datapoints verified

AI-extracted from Addus HomeCare Corp's 10-Q filed 2026-08-04 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

Addus grew Q2 FY2026 net service revenue 8.0% YoY to $377.4M, led by 10.0% growth in Personal Care, while operating income rose 18.4% to $38.9M even as gross margin slipped to 32.2%.

Biggest Revenue Drivers

Personal Care$296.0M+10.0% YoY

Organic growth in billable hours combined with the HomeCourt, Gold Horses, and Helping Hands acquisitions

Hospice$64.2M+3.3% YoY

Organic growth in average daily census and higher revenue per patient day

Biggest Revenue Drivers

Total revenue: $377.4M+8.0% YoY

Personal Care$296.0M+10.0% YoY

Organic growth in billable hours combined with the HomeCourt, Gold Horses, and Helping Hands acquisitions

Within Personal Care

Managed care organizations$139.3M+14.3% YoY

Reflects transition of business from government payors to managed care organizations

Hospice$64.2M+3.3% YoY

Organic growth in average daily census and higher revenue per patient day

Home Health$17.2M-4.8% YoY

Lower patient visits, partially offset by a favorable payor mix

Largest Expense Items

Cost of service revenues$255.9M+8.6% YoY

Rose with volume growth; increased to 67.8% of revenue from 67.4%

General and administrative expenses$78.5M+1.8% YoY

Acquisition-related wage, bonus, tax and benefit costs added $4.0M, partly offset by a $1.7M drop in professional fees

Depreciation and amortization$4.1M+5.4% YoY

Consistent with growth in depreciable and intangible asset base

Margins: Gross margin contracted to 32.2% from 32.6% YoY, driven by hospice margin compression (44.0% vs 47.9%) from higher direct wage costs, but G&A leverage improved to 20.8% of revenue from 22.1%, lifting operating margin to 10.3% from 9.4%.

Watch Items from the Filing

In May 2026 CMS issued a six-month nationwide moratorium on new Medicare enrollments for hospices and home health agencies, restricting new applications and branch expansions.
Illinois Department on Aging, the largest single payor, accounted for 17.7% of net service revenues; Illinois overall drove 32.1% of total net service revenues.
Home Health segment revenue fell 4.8% YoY to $17.2M on lower patient visits (-6.5%), with segment operating income down 25.0%.
Managed care organizations rose to 38.6% of consolidated net service revenues from 36.7% a year ago, continuing the shift away from direct government payors.
Company repaid $60.0M on its revolving credit facility in the quarter, cutting outstanding borrowings to $64.3M with $577.8M of remaining capacity.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q2 2026

$377.4M

Net Income

Q2 2026

$27.6M

Free Cash Flow

Q2 2026

$38.7M

Operating Margin

Q2 2026

10.3%

ROIC

Q2 2026

12.9%

D/E Ratio

Q2 2026

0.05

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+23.2% YoY

$1.42BFY 2025

FY22 $951.1MFY23 $1.06BFY24 $1.15BFY25 $1.42B

Net Income

+30.3% YoY

$95.9MFY 2025

FY22 $46.0MFY23 $62.5MFY24 $73.6MFY25 $95.9M

Operating Income

+35.0% YoY

$138.6MFY 2025

FY22 $68.7MFY23 $91.0MFY24 $102.7MFY25 $138.6M

EPS (Diluted)

+23.4% YoY

$5.22FY 2025

FY22 $2.84FY23 $3.83FY24 $4.23FY25 $5.22

Total Assets

+1.7% YoY

$1.44BFY 2025

FY22 $938.0MFY23 $1.02BFY24 $1.41BFY25 $1.44B

Total Debt

-44.6% YoY

$121.0MFY 2025

FY22 $131.8MFY23 $124.1MFY24 $218.4MFY25 $121.0M

Op. Cash Flow

-4.2% YoY

$111.5MFY 2025

FY22 $105.1MFY23 $112.2MFY24 $116.4MFY25 $111.5M

Free Cash Flow

-6.0% YoY

$103.8MFY 2025

FY22 $96.8MFY23 $102.8MFY24 $110.4MFY25 $103.8M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Revenue	$1.42B +23.2%	$1.15B +9.1%	$1.06B +11.3%	$951.1M +10.0%	$864.5M +13.0%	$764.8M
Net Income	$95.9M +30.3%	$73.6M +17.7%	$62.5M +35.8%	$46.0M +2.0%	$45.1M +36.2%	$33.1M
Operating Income	$138.6M +35.0%	$102.7M +12.9%	$91.0M +32.3%	$68.7M +4.2%	$65.9M +48.1%	$44.5M
EPS (Diluted)	$5.22 +23.4%	$4.23 +10.4%	$3.83 +34.9%	$2.84 +1.1%	$2.81 +35.1%	$2.08
Total Assets	$1.44B +1.7%	$1.41B +37.9%	$1.02B +9.2%	$938.0M -1.0%	$947.6M +6.2%	$892.6M
Total Debt	$121.0M -44.6%	$218.4M +76.0%	$124.1M -5.8%	$131.8M -40.4%	$220.9M +12.8%	$195.8M
Operating Cash Flow	$111.5M -4.2%	$116.4M +3.7%	$112.2M +6.8%	$105.1M +166.2%	$39.5M -63.9%	$109.4M
Free Cash Flow	$103.8M -6.0%	$110.4M +7.4%	$102.8M +6.2%	$96.8M +177.8%	$34.8M -66.0%	$102.6M

Get alerted when ADUS's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Addus HomeCare Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of ADUS

BlackRock, Inc.
$344.2M3,425,435 sh
Capital Research Global Investors
$139.6M1,389,907 sh
DIMENSIONAL FUND ADVISORS LP
$83.9M835,163 sh
VANGUARD CAPITAL MANAGEMENT LLC
$79.3M789,325 sh
STATE STREET CORP
$78.1M777,826 sh
SILVERCREST ASSET MANAGEMENT GROUP LLC
$69.4M691,246 sh
WASATCH ADVISORS LP
$68.4M680,926 sh
AMERICAN CENTURY COMPANIES INC
$56.7M564,637 sh
GEODE CAPITAL MANAGEMENT, LLC
$51.8M515,525 sh
PRINCIPAL FINANCIAL GROUP INC
$41.3M411,563 sh

Fund	Value	Shares
BlackRock, Inc.	$344.2M	3,425,435
Capital Research Global Investors	$139.6M	1,389,907
DIMENSIONAL FUND ADVISORS LP	$83.9M	835,163
VANGUARD CAPITAL MANAGEMENT LLC	$79.3M	789,325
STATE STREET CORP	$78.1M	777,826
SILVERCREST ASSET MANAGEMENT GROUP LLC	$69.4M	691,246
WASATCH ADVISORS LP	$68.4M	680,926
AMERICAN CENTURY COMPANIES INC	$56.7M	564,637
GEODE CAPITAL MANAGEMENT, LLC	$51.8M	515,525
PRINCIPAL FINANCIAL GROUP INC	$41.3M	411,563

Companies Similar to ADUS

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

PNTG

Pennant Group, Inc.

AI score

Similar quality profile · 15 shared holders

WASATCH ADVISORS LP Summit Creek Advisors LLC PEREGRINE CAPITAL MANAGEMENT LLC

MMSI

MERIT MEDICAL SYSTEMS INC

AI score

Similar quality profile · 18 shared holders

WESTWOOD HOLDINGS GROUP INC WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC SILVERCREST ASSET MANAGEMENT GROUP LLC

EHC

Encompass Health Corp

AI score

Similar quality profile · 14 shared holders

Capital Research Global Investors TimesSquare Capital Management, LLC SILVERCREST ASSET MANAGEMENT GROUP LLC

USPH

U S PHYSICAL THERAPY INC /NV

AI score

Similar quality profile · 11 shared holders

WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC KENNEDY CAPITAL MANAGEMENT LLC Bridge City Capital, LLC

CON

Concentra Group Holdings Parent, Inc.

AI score

Similar quality profile · 12 shared holders

Tributary Capital Management, LLC Dana Investment Advisors, Inc.Moran Wealth Management, LLC

Pediatrix Medical Group, Inc.

AI score

Similar quality profile · 19 shared holders

WASATCH ADVISORS LP SILVERCREST ASSET MANAGEMENT GROUP LLC Dana Investment Advisors, Inc.

ANIP

ANI PHARMACEUTICALS INC

AI score

Similar quality profile · 19 shared holders

KENNEDY CAPITAL MANAGEMENT LLC WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC Dana Investment Advisors, Inc.

HCSG

HEALTHCARE SERVICES GROUP INC

AI score

Similar quality profile · 13 shared holders

KENNEDY CAPITAL MANAGEMENT LLC RICE HALL JAMES & ASSOCIATES, LLC Bridge City Capital, LLC

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put ADUS on your watchlist

Track score changes the day Addus HomeCare Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is ADUS a good stock to buy?

13F Pro's AI-powered analysis of Addus HomeCare Corp (ADUS) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for ADUS are available on the ADUS stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. ADUS is classified as a mid company.

Which hedge funds own ADUS?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling ADUS. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Addus HomeCare Corp's investment landscape.